MannKind (MNKD) Announces Termination of Licensing Agreement with Sanofi (SNY); Will Evaluate Options for Afrezza
Tweet Send to a Friend
MannKind (NASDAQ: MNKD) announced the termination of its license and collaboration agreement with sanofi-aventis U.S. LLC for the development and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
